Casdozokitug
- Generic Name
- Casdozokitug
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2643331-37-5
- Unique Ingredient Identifier
- AL6I5N2HTN
- Associated Conditions
- -
- Associated Therapies
- -
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Coherus Biosciences, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT06679985
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath